Selected research
Industry Growth & Trends
Global Necrotizing Ulcerative Gingivitis (NUG) Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Necrotizing Ulcerative Gingivitis (NUG) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Necrotizing Ulcerative Gingivitis (NUG) market include Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics, Otsuka Pharmaceutical, GlaxoSmithKline, Mylan, Merck, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Necrotizing Ulcerative Gingivitis (NUG) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Necrotizing Ulcerative Gingivitis (NUG) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Necrotizing Ulcerative Gingivitis (NUG) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Necrotizing Ulcerative Gingivitis (NUG).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Necrotizing Ulcerative Gingivitis (NUG) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Necrotizing Ulcerative Gingivitis (NUG) Market by Company
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Otsuka Pharmaceutical
GlaxoSmithKline
Mylan
Merck
Novartis
Sanofi
Teva Pharmaceutical
Necrotizing Ulcerative Gingivitis (NUG) Segment by Type
Medication
Surgery
Necrotizing Ulcerative Gingivitis (NUG) Segment by Application
Homecare
Pharmacies
Hospitals
Others
Necrotizing Ulcerative Gingivitis (NUG) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Necrotizing Ulcerative Gingivitis (NUG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Necrotizing Ulcerative Gingivitis (NUG) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Necrotizing Ulcerative Gingivitis (NUG).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Medication
- Surgery
Applications
- Homecare
- Pharmacies
- Hospitals
- Others
Companies covered
- Abbott Laboratories
- Eli Lilly and Company
- Hindustan Antibiotics
- Otsuka Pharmaceutical
- GlaxoSmithKline
- Mylan
- Merck
- Novartis
- Sanofi
- Teva Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2021-2032)
- 1.4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2021-2026)
- 1.4.2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2027-2032)
- 1.5 Key Regions Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032)
- 1.5.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (2021-2032)
- 1.5.4 South America Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (2021-2032)
2 Necrotizing Ulcerative Gingivitis (NUG) Market by Type
- 2.1 Type Introduction
- 2.1.1 Medication
- 2.1.2 Surgery
- 2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
- 2.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Overview by Type (2021-2032)
- 2.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecasted by Type (2027-2032)
- 2.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Regions
- 2.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Type (2021-2026)
3 Necrotizing Ulcerative Gingivitis (NUG) Market by Application
- 3.1 Type Introduction
- 3.1.1 Homecare
- 3.1.2 Pharmacies
- 3.1.3 Hospitals
- 3.1.4 Others
- 3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
- 3.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Overview by Application (2021-2032)
- 3.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecasted by Application (2027-2032)
- 3.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Regions
- 3.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Necrotizing Ulcerative Gingivitis (NUG) Industry Trends
- 4.2 Necrotizing Ulcerative Gingivitis (NUG) Industry Drivers
- 4.3 Necrotizing Ulcerative Gingivitis (NUG) Industry Opportunities and Challenges
- 4.4 Necrotizing Ulcerative Gingivitis (NUG) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Necrotizing Ulcerative Gingivitis (NUG) Revenue (2021-2026)
- 5.2 Global Necrotizing Ulcerative Gingivitis (NUG) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Necrotizing Ulcerative Gingivitis (NUG) Key Company Headquarters & Area Served
- 5.4 Global Necrotizing Ulcerative Gingivitis (NUG) Company, Product Type & Application
- 5.5 Global Necrotizing Ulcerative Gingivitis (NUG) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Necrotizing Ulcerative Gingivitis (NUG) Players Market Share by Revenue in 2025
- 5.6.3 2025 Necrotizing Ulcerative Gingivitis (NUG) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott Laboratories
- 6.1.1 Abbott Laboratories Company Information
- 6.1.2 Abbott Laboratories Business Overview
- 6.1.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.1.5 Abbott Laboratories Recent Developments
- 6.2 Eli Lilly and Company
- 6.2.1 Eli Lilly and Company Company Information
- 6.2.2 Eli Lilly and Company Business Overview
- 6.2.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.2.5 Eli Lilly and Company Recent Developments
- 6.3 Hindustan Antibiotics
- 6.3.1 Hindustan Antibiotics Company Information
- 6.3.2 Hindustan Antibiotics Business Overview
- 6.3.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.3.5 Hindustan Antibiotics Recent Developments
- 6.4 Otsuka Pharmaceutical
- 6.4.1 Otsuka Pharmaceutical Company Information
- 6.4.2 Otsuka Pharmaceutical Business Overview
- 6.4.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.4.5 Otsuka Pharmaceutical Recent Developments
- 6.5 GlaxoSmithKline
- 6.5.1 GlaxoSmithKline Company Information
- 6.5.2 GlaxoSmithKline Business Overview
- 6.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.5.5 GlaxoSmithKline Recent Developments
- 6.6 Mylan
- 6.6.1 Mylan Company Information
- 6.6.2 Mylan Business Overview
- 6.6.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Mylan Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.6.5 Mylan Recent Developments
- 6.7 Merck
- 6.7.1 Merck Company Information
- 6.7.2 Merck Business Overview
- 6.7.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Merck Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.7.5 Merck Recent Developments
- 6.8 Novartis
- 6.8.1 Novartis Company Information
- 6.8.2 Novartis Business Overview
- 6.8.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Novartis Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.8.5 Novartis Recent Developments
- 6.9 Sanofi
- 6.9.1 Sanofi Company Information
- 6.9.2 Sanofi Business Overview
- 6.9.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.9.5 Sanofi Recent Developments
- 6.10 Teva Pharmaceutical
- 6.10.1 Teva Pharmaceutical Company Information
- 6.10.2 Teva Pharmaceutical Business Overview
- 6.10.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
- 6.10.5 Teva Pharmaceutical Recent Developments
7 North America
- 7.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
- 7.3 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
- 8.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
- 10.3 South America Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst